Global Mefenamic Acid Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Mefenamic acid is a member of the anthranilic acid derivatives (or fenamate) class of NSAID drugs, and is used to treat mild to moderate pain, including menstrual pain, and is sometimes used to prevent migraines associated with menstruation
LPI (LP Information)' newest research report, the “Mefenamic Acid Industry Forecast” looks at past sales and reviews total world Mefenamic Acid sales in 2022, providing a comprehensive analysis by region and market sector of projected Mefenamic Acid sales for 2023 through 2029. With Mefenamic Acid sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mefenamic Acid industry.
This Insight Report provides a comprehensive analysis of the global Mefenamic Acid landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mefenamic Acid portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Mefenamic Acid market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mefenamic Acid and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mefenamic Acid.
The global Mefenamic Acid market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Mefenamic Acid is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Mefenamic Acid is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Mefenamic Acid is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Mefenamic Acid players cover Shionogi Pharma, Solitaire Pharmacia, Shinto Organics, Captab, EMS Pharma, Adelco, Agron Remedies, IASIS Pharmaceuticals Hellas and ABL Lifecare, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Mefenamic Acid market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Mefenamic Acid market?
What factors are driving Mefenamic Acid market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mefenamic Acid market opportunities vary by end market size?
How does Mefenamic Acid break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Mefenamic acid is a member of the anthranilic acid derivatives (or fenamate) class of NSAID drugs, and is used to treat mild to moderate pain, including menstrual pain, and is sometimes used to prevent migraines associated with menstruation
LPI (LP Information)' newest research report, the “Mefenamic Acid Industry Forecast” looks at past sales and reviews total world Mefenamic Acid sales in 2022, providing a comprehensive analysis by region and market sector of projected Mefenamic Acid sales for 2023 through 2029. With Mefenamic Acid sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mefenamic Acid industry.
This Insight Report provides a comprehensive analysis of the global Mefenamic Acid landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mefenamic Acid portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Mefenamic Acid market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mefenamic Acid and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mefenamic Acid.
The global Mefenamic Acid market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Mefenamic Acid is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Mefenamic Acid is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Mefenamic Acid is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Mefenamic Acid players cover Shionogi Pharma, Solitaire Pharmacia, Shinto Organics, Captab, EMS Pharma, Adelco, Agron Remedies, IASIS Pharmaceuticals Hellas and ABL Lifecare, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Mefenamic Acid market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Patent
- Generic
- Hospital
- Drug Store
- On-line
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Shionogi Pharma
- Solitaire Pharmacia
- Shinto Organics
- Captab
- EMS Pharma
- Adelco
- Agron Remedies
- IASIS Pharmaceuticals Hellas
- ABL Lifecare
- Farmo Quimica
- Apotex
- Sanofi Aventis
- Yung Sine
- Streuli Pharma,
- Mankind
- Pfizer
- Daiichi Sankyo
- Chemidex Pharma
- AA Pharma
- Nisshin Pharmaceutical
- Koa Isei
- Teva
- Wockhardt
- Esteve
What is the 10-year outlook for the global Mefenamic Acid market?
What factors are driving Mefenamic Acid market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mefenamic Acid market opportunities vary by end market size?
How does Mefenamic Acid break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mefenamic Acid Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Mefenamic Acid by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Mefenamic Acid by Country/Region, 2018, 2022 & 2029
2.2 Mefenamic Acid Segment by Type
2.2.1 Patent
2.2.2 Generic
2.3 Mefenamic Acid Sales by Type
2.3.1 Global Mefenamic Acid Sales Market Share by Type (2018-2023)
2.3.2 Global Mefenamic Acid Revenue and Market Share by Type (2018-2023)
2.3.3 Global Mefenamic Acid Sale Price by Type (2018-2023)
2.4 Mefenamic Acid Segment by Application
2.4.1 Hospital
2.4.2 Drug Store
2.4.3 On-line
2.5 Mefenamic Acid Sales by Application
2.5.1 Global Mefenamic Acid Sale Market Share by Application (2018-2023)
2.5.2 Global Mefenamic Acid Revenue and Market Share by Application (2018-2023)
2.5.3 Global Mefenamic Acid Sale Price by Application (2018-2023)
3 GLOBAL MEFENAMIC ACID BY COMPANY
3.1 Global Mefenamic Acid Breakdown Data by Company
3.1.1 Global Mefenamic Acid Annual Sales by Company (2018-2023)
3.1.2 Global Mefenamic Acid Sales Market Share by Company (2018-2023)
3.2 Global Mefenamic Acid Annual Revenue by Company (2018-2023)
3.2.1 Global Mefenamic Acid Revenue by Company (2018-2023)
3.2.2 Global Mefenamic Acid Revenue Market Share by Company (2018-2023)
3.3 Global Mefenamic Acid Sale Price by Company
3.4 Key Manufacturers Mefenamic Acid Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mefenamic Acid Product Location Distribution
3.4.2 Players Mefenamic Acid Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MEFENAMIC ACID BY GEOGRAPHIC REGION
4.1 World Historic Mefenamic Acid Market Size by Geographic Region (2018-2023)
4.1.1 Global Mefenamic Acid Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Mefenamic Acid Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Mefenamic Acid Market Size by Country/Region (2018-2023)
4.2.1 Global Mefenamic Acid Annual Sales by Country/Region (2018-2023)
4.2.2 Global Mefenamic Acid Annual Revenue by Country/Region (2018-2023)
4.3 Americas Mefenamic Acid Sales Growth
4.4 APAC Mefenamic Acid Sales Growth
4.5 Europe Mefenamic Acid Sales Growth
4.6 Middle East & Africa Mefenamic Acid Sales Growth
5 AMERICAS
5.1 Americas Mefenamic Acid Sales by Country
5.1.1 Americas Mefenamic Acid Sales by Country (2018-2023)
5.1.2 Americas Mefenamic Acid Revenue by Country (2018-2023)
5.2 Americas Mefenamic Acid Sales by Type
5.3 Americas Mefenamic Acid Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mefenamic Acid Sales by Region
6.1.1 APAC Mefenamic Acid Sales by Region (2018-2023)
6.1.2 APAC Mefenamic Acid Revenue by Region (2018-2023)
6.2 APAC Mefenamic Acid Sales by Type
6.3 APAC Mefenamic Acid Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Mefenamic Acid by Country
7.1.1 Europe Mefenamic Acid Sales by Country (2018-2023)
7.1.2 Europe Mefenamic Acid Revenue by Country (2018-2023)
7.2 Europe Mefenamic Acid Sales by Type
7.3 Europe Mefenamic Acid Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mefenamic Acid by Country
8.1.1 Middle East & Africa Mefenamic Acid Sales by Country (2018-2023)
8.1.2 Middle East & Africa Mefenamic Acid Revenue by Country (2018-2023)
8.2 Middle East & Africa Mefenamic Acid Sales by Type
8.3 Middle East & Africa Mefenamic Acid Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mefenamic Acid
10.3 Manufacturing Process Analysis of Mefenamic Acid
10.4 Industry Chain Structure of Mefenamic Acid
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mefenamic Acid Distributors
11.3 Mefenamic Acid Customer
12 WORLD FORECAST REVIEW FOR MEFENAMIC ACID BY GEOGRAPHIC REGION
12.1 Global Mefenamic Acid Market Size Forecast by Region
12.1.1 Global Mefenamic Acid Forecast by Region (2024-2029)
12.1.2 Global Mefenamic Acid Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Mefenamic Acid Forecast by Type
12.7 Global Mefenamic Acid Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Shionogi Pharma
13.1.1 Shionogi Pharma Company Information
13.1.2 Shionogi Pharma Mefenamic Acid Product Portfolios and Specifications
13.1.3 Shionogi Pharma Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Shionogi Pharma Main Business Overview
13.1.5 Shionogi Pharma Latest Developments
13.2 Solitaire Pharmacia
13.2.1 Solitaire Pharmacia Company Information
13.2.2 Solitaire Pharmacia Mefenamic Acid Product Portfolios and Specifications
13.2.3 Solitaire Pharmacia Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Solitaire Pharmacia Main Business Overview
13.2.5 Solitaire Pharmacia Latest Developments
13.3 Shinto Organics
13.3.1 Shinto Organics Company Information
13.3.2 Shinto Organics Mefenamic Acid Product Portfolios and Specifications
13.3.3 Shinto Organics Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Shinto Organics Main Business Overview
13.3.5 Shinto Organics Latest Developments
13.4 Captab
13.4.1 Captab Company Information
13.4.2 Captab Mefenamic Acid Product Portfolios and Specifications
13.4.3 Captab Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Captab Main Business Overview
13.4.5 Captab Latest Developments
13.5 EMS Pharma
13.5.1 EMS Pharma Company Information
13.5.2 EMS Pharma Mefenamic Acid Product Portfolios and Specifications
13.5.3 EMS Pharma Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 EMS Pharma Main Business Overview
13.5.5 EMS Pharma Latest Developments
13.6 Adelco
13.6.1 Adelco Company Information
13.6.2 Adelco Mefenamic Acid Product Portfolios and Specifications
13.6.3 Adelco Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Adelco Main Business Overview
13.6.5 Adelco Latest Developments
13.7 Agron Remedies
13.7.1 Agron Remedies Company Information
13.7.2 Agron Remedies Mefenamic Acid Product Portfolios and Specifications
13.7.3 Agron Remedies Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Agron Remedies Main Business Overview
13.7.5 Agron Remedies Latest Developments
13.8 IASIS Pharmaceuticals Hellas
13.8.1 IASIS Pharmaceuticals Hellas Company Information
13.8.2 IASIS Pharmaceuticals Hellas Mefenamic Acid Product Portfolios and Specifications
13.8.3 IASIS Pharmaceuticals Hellas Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 IASIS Pharmaceuticals Hellas Main Business Overview
13.8.5 IASIS Pharmaceuticals Hellas Latest Developments
13.9 ABL Lifecare
13.9.1 ABL Lifecare Company Information
13.9.2 ABL Lifecare Mefenamic Acid Product Portfolios and Specifications
13.9.3 ABL Lifecare Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 ABL Lifecare Main Business Overview
13.9.5 ABL Lifecare Latest Developments
13.10 Farmo Quimica
13.10.1 Farmo Quimica Company Information
13.10.2 Farmo Quimica Mefenamic Acid Product Portfolios and Specifications
13.10.3 Farmo Quimica Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Farmo Quimica Main Business Overview
13.10.5 Farmo Quimica Latest Developments
13.11 Apotex
13.11.1 Apotex Company Information
13.11.2 Apotex Mefenamic Acid Product Portfolios and Specifications
13.11.3 Apotex Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Apotex Main Business Overview
13.11.5 Apotex Latest Developments
13.12 Sanofi Aventis
13.12.1 Sanofi Aventis Company Information
13.12.2 Sanofi Aventis Mefenamic Acid Product Portfolios and Specifications
13.12.3 Sanofi Aventis Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Sanofi Aventis Main Business Overview
13.12.5 Sanofi Aventis Latest Developments
13.13 Yung Sine
13.13.1 Yung Sine Company Information
13.13.2 Yung Sine Mefenamic Acid Product Portfolios and Specifications
13.13.3 Yung Sine Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Yung Sine Main Business Overview
13.13.5 Yung Sine Latest Developments
13.14 Streuli Pharma,
13.14.1 Streuli Pharma, Company Information
13.14.2 Streuli Pharma, Mefenamic Acid Product Portfolios and Specifications
13.14.3 Streuli Pharma, Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Streuli Pharma, Main Business Overview
13.14.5 Streuli Pharma, Latest Developments
13.15 Mankind
13.15.1 Mankind Company Information
13.15.2 Mankind Mefenamic Acid Product Portfolios and Specifications
13.15.3 Mankind Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Mankind Main Business Overview
13.15.5 Mankind Latest Developments
13.16 Pfizer
13.16.1 Pfizer Company Information
13.16.2 Pfizer Mefenamic Acid Product Portfolios and Specifications
13.16.3 Pfizer Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Pfizer Main Business Overview
13.16.5 Pfizer Latest Developments
13.17 Daiichi Sankyo
13.17.1 Daiichi Sankyo Company Information
13.17.2 Daiichi Sankyo Mefenamic Acid Product Portfolios and Specifications
13.17.3 Daiichi Sankyo Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Daiichi Sankyo Main Business Overview
13.17.5 Daiichi Sankyo Latest Developments
13.18 Chemidex Pharma
13.18.1 Chemidex Pharma Company Information
13.18.2 Chemidex Pharma Mefenamic Acid Product Portfolios and Specifications
13.18.3 Chemidex Pharma Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Chemidex Pharma Main Business Overview
13.18.5 Chemidex Pharma Latest Developments
13.19 AA Pharma
13.19.1 AA Pharma Company Information
13.19.2 AA Pharma Mefenamic Acid Product Portfolios and Specifications
13.19.3 AA Pharma Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 AA Pharma Main Business Overview
13.19.5 AA Pharma Latest Developments
13.20 Nisshin Pharmaceutical
13.20.1 Nisshin Pharmaceutical Company Information
13.20.2 Nisshin Pharmaceutical Mefenamic Acid Product Portfolios and Specifications
13.20.3 Nisshin Pharmaceutical Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Nisshin Pharmaceutical Main Business Overview
13.20.5 Nisshin Pharmaceutical Latest Developments
13.21 Koa Isei
13.21.1 Koa Isei Company Information
13.21.2 Koa Isei Mefenamic Acid Product Portfolios and Specifications
13.21.3 Koa Isei Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 Koa Isei Main Business Overview
13.21.5 Koa Isei Latest Developments
13.22 Teva
13.22.1 Teva Company Information
13.22.2 Teva Mefenamic Acid Product Portfolios and Specifications
13.22.3 Teva Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.22.4 Teva Main Business Overview
13.22.5 Teva Latest Developments
13.23 Wockhardt
13.23.1 Wockhardt Company Information
13.23.2 Wockhardt Mefenamic Acid Product Portfolios and Specifications
13.23.3 Wockhardt Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.23.4 Wockhardt Main Business Overview
13.23.5 Wockhardt Latest Developments
13.24 Esteve
13.24.1 Esteve Company Information
13.24.2 Esteve Mefenamic Acid Product Portfolios and Specifications
13.24.3 Esteve Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.24.4 Esteve Main Business Overview
13.24.5 Esteve Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mefenamic Acid Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Mefenamic Acid by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Mefenamic Acid by Country/Region, 2018, 2022 & 2029
2.2 Mefenamic Acid Segment by Type
2.2.1 Patent
2.2.2 Generic
2.3 Mefenamic Acid Sales by Type
2.3.1 Global Mefenamic Acid Sales Market Share by Type (2018-2023)
2.3.2 Global Mefenamic Acid Revenue and Market Share by Type (2018-2023)
2.3.3 Global Mefenamic Acid Sale Price by Type (2018-2023)
2.4 Mefenamic Acid Segment by Application
2.4.1 Hospital
2.4.2 Drug Store
2.4.3 On-line
2.5 Mefenamic Acid Sales by Application
2.5.1 Global Mefenamic Acid Sale Market Share by Application (2018-2023)
2.5.2 Global Mefenamic Acid Revenue and Market Share by Application (2018-2023)
2.5.3 Global Mefenamic Acid Sale Price by Application (2018-2023)
3 GLOBAL MEFENAMIC ACID BY COMPANY
3.1 Global Mefenamic Acid Breakdown Data by Company
3.1.1 Global Mefenamic Acid Annual Sales by Company (2018-2023)
3.1.2 Global Mefenamic Acid Sales Market Share by Company (2018-2023)
3.2 Global Mefenamic Acid Annual Revenue by Company (2018-2023)
3.2.1 Global Mefenamic Acid Revenue by Company (2018-2023)
3.2.2 Global Mefenamic Acid Revenue Market Share by Company (2018-2023)
3.3 Global Mefenamic Acid Sale Price by Company
3.4 Key Manufacturers Mefenamic Acid Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mefenamic Acid Product Location Distribution
3.4.2 Players Mefenamic Acid Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MEFENAMIC ACID BY GEOGRAPHIC REGION
4.1 World Historic Mefenamic Acid Market Size by Geographic Region (2018-2023)
4.1.1 Global Mefenamic Acid Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Mefenamic Acid Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Mefenamic Acid Market Size by Country/Region (2018-2023)
4.2.1 Global Mefenamic Acid Annual Sales by Country/Region (2018-2023)
4.2.2 Global Mefenamic Acid Annual Revenue by Country/Region (2018-2023)
4.3 Americas Mefenamic Acid Sales Growth
4.4 APAC Mefenamic Acid Sales Growth
4.5 Europe Mefenamic Acid Sales Growth
4.6 Middle East & Africa Mefenamic Acid Sales Growth
5 AMERICAS
5.1 Americas Mefenamic Acid Sales by Country
5.1.1 Americas Mefenamic Acid Sales by Country (2018-2023)
5.1.2 Americas Mefenamic Acid Revenue by Country (2018-2023)
5.2 Americas Mefenamic Acid Sales by Type
5.3 Americas Mefenamic Acid Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mefenamic Acid Sales by Region
6.1.1 APAC Mefenamic Acid Sales by Region (2018-2023)
6.1.2 APAC Mefenamic Acid Revenue by Region (2018-2023)
6.2 APAC Mefenamic Acid Sales by Type
6.3 APAC Mefenamic Acid Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Mefenamic Acid by Country
7.1.1 Europe Mefenamic Acid Sales by Country (2018-2023)
7.1.2 Europe Mefenamic Acid Revenue by Country (2018-2023)
7.2 Europe Mefenamic Acid Sales by Type
7.3 Europe Mefenamic Acid Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mefenamic Acid by Country
8.1.1 Middle East & Africa Mefenamic Acid Sales by Country (2018-2023)
8.1.2 Middle East & Africa Mefenamic Acid Revenue by Country (2018-2023)
8.2 Middle East & Africa Mefenamic Acid Sales by Type
8.3 Middle East & Africa Mefenamic Acid Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mefenamic Acid
10.3 Manufacturing Process Analysis of Mefenamic Acid
10.4 Industry Chain Structure of Mefenamic Acid
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mefenamic Acid Distributors
11.3 Mefenamic Acid Customer
12 WORLD FORECAST REVIEW FOR MEFENAMIC ACID BY GEOGRAPHIC REGION
12.1 Global Mefenamic Acid Market Size Forecast by Region
12.1.1 Global Mefenamic Acid Forecast by Region (2024-2029)
12.1.2 Global Mefenamic Acid Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Mefenamic Acid Forecast by Type
12.7 Global Mefenamic Acid Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Shionogi Pharma
13.1.1 Shionogi Pharma Company Information
13.1.2 Shionogi Pharma Mefenamic Acid Product Portfolios and Specifications
13.1.3 Shionogi Pharma Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Shionogi Pharma Main Business Overview
13.1.5 Shionogi Pharma Latest Developments
13.2 Solitaire Pharmacia
13.2.1 Solitaire Pharmacia Company Information
13.2.2 Solitaire Pharmacia Mefenamic Acid Product Portfolios and Specifications
13.2.3 Solitaire Pharmacia Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Solitaire Pharmacia Main Business Overview
13.2.5 Solitaire Pharmacia Latest Developments
13.3 Shinto Organics
13.3.1 Shinto Organics Company Information
13.3.2 Shinto Organics Mefenamic Acid Product Portfolios and Specifications
13.3.3 Shinto Organics Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Shinto Organics Main Business Overview
13.3.5 Shinto Organics Latest Developments
13.4 Captab
13.4.1 Captab Company Information
13.4.2 Captab Mefenamic Acid Product Portfolios and Specifications
13.4.3 Captab Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Captab Main Business Overview
13.4.5 Captab Latest Developments
13.5 EMS Pharma
13.5.1 EMS Pharma Company Information
13.5.2 EMS Pharma Mefenamic Acid Product Portfolios and Specifications
13.5.3 EMS Pharma Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 EMS Pharma Main Business Overview
13.5.5 EMS Pharma Latest Developments
13.6 Adelco
13.6.1 Adelco Company Information
13.6.2 Adelco Mefenamic Acid Product Portfolios and Specifications
13.6.3 Adelco Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Adelco Main Business Overview
13.6.5 Adelco Latest Developments
13.7 Agron Remedies
13.7.1 Agron Remedies Company Information
13.7.2 Agron Remedies Mefenamic Acid Product Portfolios and Specifications
13.7.3 Agron Remedies Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Agron Remedies Main Business Overview
13.7.5 Agron Remedies Latest Developments
13.8 IASIS Pharmaceuticals Hellas
13.8.1 IASIS Pharmaceuticals Hellas Company Information
13.8.2 IASIS Pharmaceuticals Hellas Mefenamic Acid Product Portfolios and Specifications
13.8.3 IASIS Pharmaceuticals Hellas Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 IASIS Pharmaceuticals Hellas Main Business Overview
13.8.5 IASIS Pharmaceuticals Hellas Latest Developments
13.9 ABL Lifecare
13.9.1 ABL Lifecare Company Information
13.9.2 ABL Lifecare Mefenamic Acid Product Portfolios and Specifications
13.9.3 ABL Lifecare Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 ABL Lifecare Main Business Overview
13.9.5 ABL Lifecare Latest Developments
13.10 Farmo Quimica
13.10.1 Farmo Quimica Company Information
13.10.2 Farmo Quimica Mefenamic Acid Product Portfolios and Specifications
13.10.3 Farmo Quimica Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Farmo Quimica Main Business Overview
13.10.5 Farmo Quimica Latest Developments
13.11 Apotex
13.11.1 Apotex Company Information
13.11.2 Apotex Mefenamic Acid Product Portfolios and Specifications
13.11.3 Apotex Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Apotex Main Business Overview
13.11.5 Apotex Latest Developments
13.12 Sanofi Aventis
13.12.1 Sanofi Aventis Company Information
13.12.2 Sanofi Aventis Mefenamic Acid Product Portfolios and Specifications
13.12.3 Sanofi Aventis Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Sanofi Aventis Main Business Overview
13.12.5 Sanofi Aventis Latest Developments
13.13 Yung Sine
13.13.1 Yung Sine Company Information
13.13.2 Yung Sine Mefenamic Acid Product Portfolios and Specifications
13.13.3 Yung Sine Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Yung Sine Main Business Overview
13.13.5 Yung Sine Latest Developments
13.14 Streuli Pharma,
13.14.1 Streuli Pharma, Company Information
13.14.2 Streuli Pharma, Mefenamic Acid Product Portfolios and Specifications
13.14.3 Streuli Pharma, Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Streuli Pharma, Main Business Overview
13.14.5 Streuli Pharma, Latest Developments
13.15 Mankind
13.15.1 Mankind Company Information
13.15.2 Mankind Mefenamic Acid Product Portfolios and Specifications
13.15.3 Mankind Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Mankind Main Business Overview
13.15.5 Mankind Latest Developments
13.16 Pfizer
13.16.1 Pfizer Company Information
13.16.2 Pfizer Mefenamic Acid Product Portfolios and Specifications
13.16.3 Pfizer Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Pfizer Main Business Overview
13.16.5 Pfizer Latest Developments
13.17 Daiichi Sankyo
13.17.1 Daiichi Sankyo Company Information
13.17.2 Daiichi Sankyo Mefenamic Acid Product Portfolios and Specifications
13.17.3 Daiichi Sankyo Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Daiichi Sankyo Main Business Overview
13.17.5 Daiichi Sankyo Latest Developments
13.18 Chemidex Pharma
13.18.1 Chemidex Pharma Company Information
13.18.2 Chemidex Pharma Mefenamic Acid Product Portfolios and Specifications
13.18.3 Chemidex Pharma Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Chemidex Pharma Main Business Overview
13.18.5 Chemidex Pharma Latest Developments
13.19 AA Pharma
13.19.1 AA Pharma Company Information
13.19.2 AA Pharma Mefenamic Acid Product Portfolios and Specifications
13.19.3 AA Pharma Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 AA Pharma Main Business Overview
13.19.5 AA Pharma Latest Developments
13.20 Nisshin Pharmaceutical
13.20.1 Nisshin Pharmaceutical Company Information
13.20.2 Nisshin Pharmaceutical Mefenamic Acid Product Portfolios and Specifications
13.20.3 Nisshin Pharmaceutical Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Nisshin Pharmaceutical Main Business Overview
13.20.5 Nisshin Pharmaceutical Latest Developments
13.21 Koa Isei
13.21.1 Koa Isei Company Information
13.21.2 Koa Isei Mefenamic Acid Product Portfolios and Specifications
13.21.3 Koa Isei Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 Koa Isei Main Business Overview
13.21.5 Koa Isei Latest Developments
13.22 Teva
13.22.1 Teva Company Information
13.22.2 Teva Mefenamic Acid Product Portfolios and Specifications
13.22.3 Teva Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.22.4 Teva Main Business Overview
13.22.5 Teva Latest Developments
13.23 Wockhardt
13.23.1 Wockhardt Company Information
13.23.2 Wockhardt Mefenamic Acid Product Portfolios and Specifications
13.23.3 Wockhardt Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.23.4 Wockhardt Main Business Overview
13.23.5 Wockhardt Latest Developments
13.24 Esteve
13.24.1 Esteve Company Information
13.24.2 Esteve Mefenamic Acid Product Portfolios and Specifications
13.24.3 Esteve Mefenamic Acid Sales, Revenue, Price and Gross Margin (2018-2023)
13.24.4 Esteve Main Business Overview
13.24.5 Esteve Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Mefenamic Acid Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Mefenamic Acid Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Patent
Table 4. Major Players of Generic
Table 5. Global Mefenamic Acid Sales by Type (2018-2023) & (K Units)
Table 6. Global Mefenamic Acid Sales Market Share by Type (2018-2023)
Table 7. Global Mefenamic Acid Revenue by Type (2018-2023) & ($ million)
Table 8. Global Mefenamic Acid Revenue Market Share by Type (2018-2023)
Table 9. Global Mefenamic Acid Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Mefenamic Acid Sales by Application (2018-2023) & (K Units)
Table 11. Global Mefenamic Acid Sales Market Share by Application (2018-2023)
Table 12. Global Mefenamic Acid Revenue by Application (2018-2023)
Table 13. Global Mefenamic Acid Revenue Market Share by Application (2018-2023)
Table 14. Global Mefenamic Acid Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Mefenamic Acid Sales by Company (2018-2023) & (K Units)
Table 16. Global Mefenamic Acid Sales Market Share by Company (2018-2023)
Table 17. Global Mefenamic Acid Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Mefenamic Acid Revenue Market Share by Company (2018-2023)
Table 19. Global Mefenamic Acid Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Mefenamic Acid Producing Area Distribution and Sales Area
Table 21. Players Mefenamic Acid Products Offered
Table 22. Mefenamic Acid Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Mefenamic Acid Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Mefenamic Acid Sales Market Share Geographic Region (2018-2023)
Table 27. Global Mefenamic Acid Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Mefenamic Acid Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Mefenamic Acid Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Mefenamic Acid Sales Market Share by Country/Region (2018-2023)
Table 31. Global Mefenamic Acid Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Mefenamic Acid Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Mefenamic Acid Sales by Country (2018-2023) & (K Units)
Table 34. Americas Mefenamic Acid Sales Market Share by Country (2018-2023)
Table 35. Americas Mefenamic Acid Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Mefenamic Acid Revenue Market Share by Country (2018-2023)
Table 37. Americas Mefenamic Acid Sales by Type (2018-2023) & (K Units)
Table 38. Americas Mefenamic Acid Sales by Application (2018-2023) & (K Units)
Table 39. APAC Mefenamic Acid Sales by Region (2018-2023) & (K Units)
Table 40. APAC Mefenamic Acid Sales Market Share by Region (2018-2023)
Table 41. APAC Mefenamic Acid Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Mefenamic Acid Revenue Market Share by Region (2018-2023)
Table 43. APAC Mefenamic Acid Sales by Type (2018-2023) & (K Units)
Table 44. APAC Mefenamic Acid Sales by Application (2018-2023) & (K Units)
Table 45. Europe Mefenamic Acid Sales by Country (2018-2023) & (K Units)
Table 46. Europe Mefenamic Acid Sales Market Share by Country (2018-2023)
Table 47. Europe Mefenamic Acid Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Mefenamic Acid Revenue Market Share by Country (2018-2023)
Table 49. Europe Mefenamic Acid Sales by Type (2018-2023) & (K Units)
Table 50. Europe Mefenamic Acid Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Mefenamic Acid Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Mefenamic Acid Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Mefenamic Acid Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Mefenamic Acid Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Mefenamic Acid Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Mefenamic Acid Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Mefenamic Acid
Table 58. Key Market Challenges & Risks of Mefenamic Acid
Table 59. Key Industry Trends of Mefenamic Acid
Table 60. Mefenamic Acid Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Mefenamic Acid Distributors List
Table 63. Mefenamic Acid Customer List
Table 64. Global Mefenamic Acid Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Mefenamic Acid Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Mefenamic Acid Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Mefenamic Acid Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Mefenamic Acid Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Mefenamic Acid Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Mefenamic Acid Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Mefenamic Acid Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Mefenamic Acid Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Mefenamic Acid Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Mefenamic Acid Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Mefenamic Acid Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Mefenamic Acid Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Mefenamic Acid Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Shionogi Pharma Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 79. Shionogi Pharma Mefenamic Acid Product Portfolios and Specifications
Table 80. Shionogi Pharma Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Shionogi Pharma Main Business
Table 82. Shionogi Pharma Latest Developments
Table 83. Solitaire Pharmacia Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 84. Solitaire Pharmacia Mefenamic Acid Product Portfolios and Specifications
Table 85. Solitaire Pharmacia Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Solitaire Pharmacia Main Business
Table 87. Solitaire Pharmacia Latest Developments
Table 88. Shinto Organics Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 89. Shinto Organics Mefenamic Acid Product Portfolios and Specifications
Table 90. Shinto Organics Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Shinto Organics Main Business
Table 92. Shinto Organics Latest Developments
Table 93. Captab Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 94. Captab Mefenamic Acid Product Portfolios and Specifications
Table 95. Captab Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Captab Main Business
Table 97. Captab Latest Developments
Table 98. EMS Pharma Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 99. EMS Pharma Mefenamic Acid Product Portfolios and Specifications
Table 100. EMS Pharma Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. EMS Pharma Main Business
Table 102. EMS Pharma Latest Developments
Table 103. Adelco Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 104. Adelco Mefenamic Acid Product Portfolios and Specifications
Table 105. Adelco Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Adelco Main Business
Table 107. Adelco Latest Developments
Table 108. Agron Remedies Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 109. Agron Remedies Mefenamic Acid Product Portfolios and Specifications
Table 110. Agron Remedies Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Agron Remedies Main Business
Table 112. Agron Remedies Latest Developments
Table 113. IASIS Pharmaceuticals Hellas Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 114. IASIS Pharmaceuticals Hellas Mefenamic Acid Product Portfolios and Specifications
Table 115. IASIS Pharmaceuticals Hellas Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. IASIS Pharmaceuticals Hellas Main Business
Table 117. IASIS Pharmaceuticals Hellas Latest Developments
Table 118. ABL Lifecare Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 119. ABL Lifecare Mefenamic Acid Product Portfolios and Specifications
Table 120. ABL Lifecare Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. ABL Lifecare Main Business
Table 122. ABL Lifecare Latest Developments
Table 123. Farmo Quimica Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 124. Farmo Quimica Mefenamic Acid Product Portfolios and Specifications
Table 125. Farmo Quimica Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Farmo Quimica Main Business
Table 127. Farmo Quimica Latest Developments
Table 128. Apotex Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 129. Apotex Mefenamic Acid Product Portfolios and Specifications
Table 130. Apotex Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Apotex Main Business
Table 132. Apotex Latest Developments
Table 133. Sanofi Aventis Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 134. Sanofi Aventis Mefenamic Acid Product Portfolios and Specifications
Table 135. Sanofi Aventis Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Sanofi Aventis Main Business
Table 137. Sanofi Aventis Latest Developments
Table 138. Yung Sine Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 139. Yung Sine Mefenamic Acid Product Portfolios and Specifications
Table 140. Yung Sine Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Yung Sine Main Business
Table 142. Yung Sine Latest Developments
Table 143. Streuli Pharma, Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 144. Streuli Pharma, Mefenamic Acid Product Portfolios and Specifications
Table 145. Streuli Pharma, Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Streuli Pharma, Main Business
Table 147. Streuli Pharma, Latest Developments
Table 148. Mankind Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 149. Mankind Mefenamic Acid Product Portfolios and Specifications
Table 150. Mankind Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Mankind Main Business
Table 152. Mankind Latest Developments
Table 153. Pfizer Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 154. Pfizer Mefenamic Acid Product Portfolios and Specifications
Table 155. Pfizer Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Pfizer Main Business
Table 157. Pfizer Latest Developments
Table 158. Daiichi Sankyo Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 159. Daiichi Sankyo Mefenamic Acid Product Portfolios and Specifications
Table 160. Daiichi Sankyo Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. Daiichi Sankyo Main Business
Table 162. Daiichi Sankyo Latest Developments
Table 163. Chemidex Pharma Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 164. Chemidex Pharma Mefenamic Acid Product Portfolios and Specifications
Table 165. Chemidex Pharma Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 166. Chemidex Pharma Main Business
Table 167. Chemidex Pharma Latest Developments
Table 168. AA Pharma Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 169. AA Pharma Mefenamic Acid Product Portfolios and Specifications
Table 170. AA Pharma Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 171. AA Pharma Main Business
Table 172. AA Pharma Latest Developments
Table 173. Nisshin Pharmaceutical Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 174. Nisshin Pharmaceutical Mefenamic Acid Product Portfolios and Specifications
Table 175. Nisshin Pharmaceutical Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 176. Nisshin Pharmaceutical Main Business
Table 177. Nisshin Pharmaceutical Latest Developments
Table 178. Koa Isei Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 179. Koa Isei Mefenamic Acid Product Portfolios and Specifications
Table 180. Koa Isei Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 181. Koa Isei Main Business
Table 182. Koa Isei Latest Developments
Table 183. Teva Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 184. Teva Mefenamic Acid Product Portfolios and Specifications
Table 185. Teva Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 186. Teva Main Business
Table 187. Teva Latest Developments
Table 188. Wockhardt Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 189. Wockhardt Mefenamic Acid Product Portfolios and Specifications
Table 190. Wockhardt Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 191. Wockhardt Main Business
Table 192. Wockhardt Latest Developments
Table 193. Esteve Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 194. Esteve Mefenamic Acid Product Portfolios and Specifications
Table 195. Esteve Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 196. Esteve Main Business
Table 197. Esteve Latest Developments
Table 1. Mefenamic Acid Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Mefenamic Acid Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Patent
Table 4. Major Players of Generic
Table 5. Global Mefenamic Acid Sales by Type (2018-2023) & (K Units)
Table 6. Global Mefenamic Acid Sales Market Share by Type (2018-2023)
Table 7. Global Mefenamic Acid Revenue by Type (2018-2023) & ($ million)
Table 8. Global Mefenamic Acid Revenue Market Share by Type (2018-2023)
Table 9. Global Mefenamic Acid Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Mefenamic Acid Sales by Application (2018-2023) & (K Units)
Table 11. Global Mefenamic Acid Sales Market Share by Application (2018-2023)
Table 12. Global Mefenamic Acid Revenue by Application (2018-2023)
Table 13. Global Mefenamic Acid Revenue Market Share by Application (2018-2023)
Table 14. Global Mefenamic Acid Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Mefenamic Acid Sales by Company (2018-2023) & (K Units)
Table 16. Global Mefenamic Acid Sales Market Share by Company (2018-2023)
Table 17. Global Mefenamic Acid Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Mefenamic Acid Revenue Market Share by Company (2018-2023)
Table 19. Global Mefenamic Acid Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Mefenamic Acid Producing Area Distribution and Sales Area
Table 21. Players Mefenamic Acid Products Offered
Table 22. Mefenamic Acid Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Mefenamic Acid Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Mefenamic Acid Sales Market Share Geographic Region (2018-2023)
Table 27. Global Mefenamic Acid Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Mefenamic Acid Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Mefenamic Acid Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Mefenamic Acid Sales Market Share by Country/Region (2018-2023)
Table 31. Global Mefenamic Acid Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Mefenamic Acid Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Mefenamic Acid Sales by Country (2018-2023) & (K Units)
Table 34. Americas Mefenamic Acid Sales Market Share by Country (2018-2023)
Table 35. Americas Mefenamic Acid Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Mefenamic Acid Revenue Market Share by Country (2018-2023)
Table 37. Americas Mefenamic Acid Sales by Type (2018-2023) & (K Units)
Table 38. Americas Mefenamic Acid Sales by Application (2018-2023) & (K Units)
Table 39. APAC Mefenamic Acid Sales by Region (2018-2023) & (K Units)
Table 40. APAC Mefenamic Acid Sales Market Share by Region (2018-2023)
Table 41. APAC Mefenamic Acid Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Mefenamic Acid Revenue Market Share by Region (2018-2023)
Table 43. APAC Mefenamic Acid Sales by Type (2018-2023) & (K Units)
Table 44. APAC Mefenamic Acid Sales by Application (2018-2023) & (K Units)
Table 45. Europe Mefenamic Acid Sales by Country (2018-2023) & (K Units)
Table 46. Europe Mefenamic Acid Sales Market Share by Country (2018-2023)
Table 47. Europe Mefenamic Acid Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Mefenamic Acid Revenue Market Share by Country (2018-2023)
Table 49. Europe Mefenamic Acid Sales by Type (2018-2023) & (K Units)
Table 50. Europe Mefenamic Acid Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Mefenamic Acid Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Mefenamic Acid Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Mefenamic Acid Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Mefenamic Acid Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Mefenamic Acid Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Mefenamic Acid Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Mefenamic Acid
Table 58. Key Market Challenges & Risks of Mefenamic Acid
Table 59. Key Industry Trends of Mefenamic Acid
Table 60. Mefenamic Acid Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Mefenamic Acid Distributors List
Table 63. Mefenamic Acid Customer List
Table 64. Global Mefenamic Acid Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Mefenamic Acid Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Mefenamic Acid Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Mefenamic Acid Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Mefenamic Acid Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Mefenamic Acid Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Mefenamic Acid Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Mefenamic Acid Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Mefenamic Acid Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Mefenamic Acid Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Mefenamic Acid Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Mefenamic Acid Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Mefenamic Acid Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Mefenamic Acid Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Shionogi Pharma Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 79. Shionogi Pharma Mefenamic Acid Product Portfolios and Specifications
Table 80. Shionogi Pharma Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Shionogi Pharma Main Business
Table 82. Shionogi Pharma Latest Developments
Table 83. Solitaire Pharmacia Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 84. Solitaire Pharmacia Mefenamic Acid Product Portfolios and Specifications
Table 85. Solitaire Pharmacia Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Solitaire Pharmacia Main Business
Table 87. Solitaire Pharmacia Latest Developments
Table 88. Shinto Organics Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 89. Shinto Organics Mefenamic Acid Product Portfolios and Specifications
Table 90. Shinto Organics Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Shinto Organics Main Business
Table 92. Shinto Organics Latest Developments
Table 93. Captab Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 94. Captab Mefenamic Acid Product Portfolios and Specifications
Table 95. Captab Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Captab Main Business
Table 97. Captab Latest Developments
Table 98. EMS Pharma Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 99. EMS Pharma Mefenamic Acid Product Portfolios and Specifications
Table 100. EMS Pharma Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. EMS Pharma Main Business
Table 102. EMS Pharma Latest Developments
Table 103. Adelco Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 104. Adelco Mefenamic Acid Product Portfolios and Specifications
Table 105. Adelco Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Adelco Main Business
Table 107. Adelco Latest Developments
Table 108. Agron Remedies Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 109. Agron Remedies Mefenamic Acid Product Portfolios and Specifications
Table 110. Agron Remedies Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Agron Remedies Main Business
Table 112. Agron Remedies Latest Developments
Table 113. IASIS Pharmaceuticals Hellas Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 114. IASIS Pharmaceuticals Hellas Mefenamic Acid Product Portfolios and Specifications
Table 115. IASIS Pharmaceuticals Hellas Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. IASIS Pharmaceuticals Hellas Main Business
Table 117. IASIS Pharmaceuticals Hellas Latest Developments
Table 118. ABL Lifecare Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 119. ABL Lifecare Mefenamic Acid Product Portfolios and Specifications
Table 120. ABL Lifecare Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. ABL Lifecare Main Business
Table 122. ABL Lifecare Latest Developments
Table 123. Farmo Quimica Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 124. Farmo Quimica Mefenamic Acid Product Portfolios and Specifications
Table 125. Farmo Quimica Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Farmo Quimica Main Business
Table 127. Farmo Quimica Latest Developments
Table 128. Apotex Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 129. Apotex Mefenamic Acid Product Portfolios and Specifications
Table 130. Apotex Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Apotex Main Business
Table 132. Apotex Latest Developments
Table 133. Sanofi Aventis Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 134. Sanofi Aventis Mefenamic Acid Product Portfolios and Specifications
Table 135. Sanofi Aventis Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Sanofi Aventis Main Business
Table 137. Sanofi Aventis Latest Developments
Table 138. Yung Sine Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 139. Yung Sine Mefenamic Acid Product Portfolios and Specifications
Table 140. Yung Sine Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Yung Sine Main Business
Table 142. Yung Sine Latest Developments
Table 143. Streuli Pharma, Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 144. Streuli Pharma, Mefenamic Acid Product Portfolios and Specifications
Table 145. Streuli Pharma, Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Streuli Pharma, Main Business
Table 147. Streuli Pharma, Latest Developments
Table 148. Mankind Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 149. Mankind Mefenamic Acid Product Portfolios and Specifications
Table 150. Mankind Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Mankind Main Business
Table 152. Mankind Latest Developments
Table 153. Pfizer Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 154. Pfizer Mefenamic Acid Product Portfolios and Specifications
Table 155. Pfizer Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Pfizer Main Business
Table 157. Pfizer Latest Developments
Table 158. Daiichi Sankyo Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 159. Daiichi Sankyo Mefenamic Acid Product Portfolios and Specifications
Table 160. Daiichi Sankyo Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. Daiichi Sankyo Main Business
Table 162. Daiichi Sankyo Latest Developments
Table 163. Chemidex Pharma Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 164. Chemidex Pharma Mefenamic Acid Product Portfolios and Specifications
Table 165. Chemidex Pharma Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 166. Chemidex Pharma Main Business
Table 167. Chemidex Pharma Latest Developments
Table 168. AA Pharma Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 169. AA Pharma Mefenamic Acid Product Portfolios and Specifications
Table 170. AA Pharma Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 171. AA Pharma Main Business
Table 172. AA Pharma Latest Developments
Table 173. Nisshin Pharmaceutical Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 174. Nisshin Pharmaceutical Mefenamic Acid Product Portfolios and Specifications
Table 175. Nisshin Pharmaceutical Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 176. Nisshin Pharmaceutical Main Business
Table 177. Nisshin Pharmaceutical Latest Developments
Table 178. Koa Isei Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 179. Koa Isei Mefenamic Acid Product Portfolios and Specifications
Table 180. Koa Isei Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 181. Koa Isei Main Business
Table 182. Koa Isei Latest Developments
Table 183. Teva Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 184. Teva Mefenamic Acid Product Portfolios and Specifications
Table 185. Teva Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 186. Teva Main Business
Table 187. Teva Latest Developments
Table 188. Wockhardt Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 189. Wockhardt Mefenamic Acid Product Portfolios and Specifications
Table 190. Wockhardt Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 191. Wockhardt Main Business
Table 192. Wockhardt Latest Developments
Table 193. Esteve Basic Information, Mefenamic Acid Manufacturing Base, Sales Area and Its Competitors
Table 194. Esteve Mefenamic Acid Product Portfolios and Specifications
Table 195. Esteve Mefenamic Acid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 196. Esteve Main Business
Table 197. Esteve Latest Developments
LIST OF FIGURES
Figure 1. Picture of Mefenamic Acid
Figure 2. Mefenamic Acid Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mefenamic Acid Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Mefenamic Acid Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Mefenamic Acid Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Patent
Figure 10. Product Picture of Generic
Figure 11. Global Mefenamic Acid Sales Market Share by Type in 2022
Figure 12. Global Mefenamic Acid Revenue Market Share by Type (2018-2023)
Figure 13. Mefenamic Acid Consumed in Hospital
Figure 14. Global Mefenamic Acid Market: Hospital (2018-2023) & (K Units)
Figure 15. Mefenamic Acid Consumed in Drug Store
Figure 16. Global Mefenamic Acid Market: Drug Store (2018-2023) & (K Units)
Figure 17. Mefenamic Acid Consumed in On-line
Figure 18. Global Mefenamic Acid Market: On-line (2018-2023) & (K Units)
Figure 19. Global Mefenamic Acid Sales Market Share by Application (2022)
Figure 20. Global Mefenamic Acid Revenue Market Share by Application in 2022
Figure 21. Mefenamic Acid Sales Market by Company in 2022 (K Units)
Figure 22. Global Mefenamic Acid Sales Market Share by Company in 2022
Figure 23. Mefenamic Acid Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Mefenamic Acid Revenue Market Share by Company in 2022
Figure 25. Global Mefenamic Acid Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Mefenamic Acid Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Mefenamic Acid Sales 2018-2023 (K Units)
Figure 28. Americas Mefenamic Acid Revenue 2018-2023 ($ Millions)
Figure 29. APAC Mefenamic Acid Sales 2018-2023 (K Units)
Figure 30. APAC Mefenamic Acid Revenue 2018-2023 ($ Millions)
Figure 31. Europe Mefenamic Acid Sales 2018-2023 (K Units)
Figure 32. Europe Mefenamic Acid Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Mefenamic Acid Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Mefenamic Acid Revenue 2018-2023 ($ Millions)
Figure 35. Americas Mefenamic Acid Sales Market Share by Country in 2022
Figure 36. Americas Mefenamic Acid Revenue Market Share by Country in 2022
Figure 37. Americas Mefenamic Acid Sales Market Share by Type (2018-2023)
Figure 38. Americas Mefenamic Acid Sales Market Share by Application (2018-2023)
Figure 39. United States Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Mefenamic Acid Sales Market Share by Region in 2022
Figure 44. APAC Mefenamic Acid Revenue Market Share by Regions in 2022
Figure 45. APAC Mefenamic Acid Sales Market Share by Type (2018-2023)
Figure 46. APAC Mefenamic Acid Sales Market Share by Application (2018-2023)
Figure 47. China Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Mefenamic Acid Sales Market Share by Country in 2022
Figure 55. Europe Mefenamic Acid Revenue Market Share by Country in 2022
Figure 56. Europe Mefenamic Acid Sales Market Share by Type (2018-2023)
Figure 57. Europe Mefenamic Acid Sales Market Share by Application (2018-2023)
Figure 58. Germany Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Mefenamic Acid Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Mefenamic Acid Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Mefenamic Acid Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Mefenamic Acid Sales Market Share by Application (2018-2023)
Figure 67. Egypt Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Mefenamic Acid in 2022
Figure 73. Manufacturing Process Analysis of Mefenamic Acid
Figure 74. Industry Chain Structure of Mefenamic Acid
Figure 75. Channels of Distribution
Figure 76. Global Mefenamic Acid Sales Market Forecast by Region (2024-2029)
Figure 77. Global Mefenamic Acid Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Mefenamic Acid Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Mefenamic Acid Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Mefenamic Acid Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Mefenamic Acid Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Mefenamic Acid
Figure 2. Mefenamic Acid Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mefenamic Acid Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Mefenamic Acid Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Mefenamic Acid Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Patent
Figure 10. Product Picture of Generic
Figure 11. Global Mefenamic Acid Sales Market Share by Type in 2022
Figure 12. Global Mefenamic Acid Revenue Market Share by Type (2018-2023)
Figure 13. Mefenamic Acid Consumed in Hospital
Figure 14. Global Mefenamic Acid Market: Hospital (2018-2023) & (K Units)
Figure 15. Mefenamic Acid Consumed in Drug Store
Figure 16. Global Mefenamic Acid Market: Drug Store (2018-2023) & (K Units)
Figure 17. Mefenamic Acid Consumed in On-line
Figure 18. Global Mefenamic Acid Market: On-line (2018-2023) & (K Units)
Figure 19. Global Mefenamic Acid Sales Market Share by Application (2022)
Figure 20. Global Mefenamic Acid Revenue Market Share by Application in 2022
Figure 21. Mefenamic Acid Sales Market by Company in 2022 (K Units)
Figure 22. Global Mefenamic Acid Sales Market Share by Company in 2022
Figure 23. Mefenamic Acid Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Mefenamic Acid Revenue Market Share by Company in 2022
Figure 25. Global Mefenamic Acid Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Mefenamic Acid Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Mefenamic Acid Sales 2018-2023 (K Units)
Figure 28. Americas Mefenamic Acid Revenue 2018-2023 ($ Millions)
Figure 29. APAC Mefenamic Acid Sales 2018-2023 (K Units)
Figure 30. APAC Mefenamic Acid Revenue 2018-2023 ($ Millions)
Figure 31. Europe Mefenamic Acid Sales 2018-2023 (K Units)
Figure 32. Europe Mefenamic Acid Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Mefenamic Acid Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Mefenamic Acid Revenue 2018-2023 ($ Millions)
Figure 35. Americas Mefenamic Acid Sales Market Share by Country in 2022
Figure 36. Americas Mefenamic Acid Revenue Market Share by Country in 2022
Figure 37. Americas Mefenamic Acid Sales Market Share by Type (2018-2023)
Figure 38. Americas Mefenamic Acid Sales Market Share by Application (2018-2023)
Figure 39. United States Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Mefenamic Acid Sales Market Share by Region in 2022
Figure 44. APAC Mefenamic Acid Revenue Market Share by Regions in 2022
Figure 45. APAC Mefenamic Acid Sales Market Share by Type (2018-2023)
Figure 46. APAC Mefenamic Acid Sales Market Share by Application (2018-2023)
Figure 47. China Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Mefenamic Acid Sales Market Share by Country in 2022
Figure 55. Europe Mefenamic Acid Revenue Market Share by Country in 2022
Figure 56. Europe Mefenamic Acid Sales Market Share by Type (2018-2023)
Figure 57. Europe Mefenamic Acid Sales Market Share by Application (2018-2023)
Figure 58. Germany Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Mefenamic Acid Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Mefenamic Acid Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Mefenamic Acid Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Mefenamic Acid Sales Market Share by Application (2018-2023)
Figure 67. Egypt Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Mefenamic Acid Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Mefenamic Acid in 2022
Figure 73. Manufacturing Process Analysis of Mefenamic Acid
Figure 74. Industry Chain Structure of Mefenamic Acid
Figure 75. Channels of Distribution
Figure 76. Global Mefenamic Acid Sales Market Forecast by Region (2024-2029)
Figure 77. Global Mefenamic Acid Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Mefenamic Acid Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Mefenamic Acid Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Mefenamic Acid Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Mefenamic Acid Revenue Market Share Forecast by Application (2024-2029)
More Publications
Global DR Detector Market Growth 2023-2029
US$ 3,660.00
February 2023
102 pages
Global Pharmaceutical Lipids Market Growth 2023-2029
US$ 3,660.00
February 2023
98 pages
Global Ketorolac Injection Market Growth 2026-2032
US$ 3,660.00
May 2026
137 pages
Global Dealing Abutment Market Growth 2024-2030
US$ 3,660.00
September 2024
140 pages
Global Ofloxacin Eye Drops Market Growth 2025-2031
US$ 3,660.00
October 2025
133 pages
